BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9179370)

  • 1. Isolation and characterization of biologically active lectin from Korean mistletoe, Viscum album var. Coloratum.
    Lee HS; Kim YS; Kim SB; Choi BE; Woo BH; Lee KC
    Cell Mol Life Sci; 1999 Apr; 55(4):679-82. PubMed ID: 10357236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mistletoe: for cancer or just for Christmas?
    de Giorgio A; Stebbing J
    Lancet Oncol; 2013 Dec; 14(13):1264-5. PubMed ID: 24275128
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model.
    Thies A; Dautel P; Meyer A; Pfüller U; Schumacher U
    Br J Cancer; 2008 Jan; 98(1):106-12. PubMed ID: 18026191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe-treated cancer patients.
    Fischer S; Scheffler A; Kabelitz D
    Cancer Immunol Immunother; 1997 May; 44(3):150-6. PubMed ID: 9191874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy.
    Maletzki C; Linnebacher M; Savai R; Hobohm U
    Cancer Immunol Immunother; 2013 Aug; 62(8):1283-92. PubMed ID: 23832140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lectins with potential for anti-cancer therapy.
    Yau T; Dan X; Ng CC; Ng TB
    Molecules; 2015 Feb; 20(3):3791-810. PubMed ID: 25730388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.
    Finall AI; McIntosh SA; Thompson WD
    BMJ; 2006 Dec; 333(7582):1293-4. PubMed ID: 17185712
    [No Abstract]   [Full Text] [Related]  

  • 8. Mistletoe as an Anti-Hemorrhagic.
    Indep Pract; 1881 Jul; 2(7):394-395. PubMed ID: 37825337
    [No Abstract]   [Full Text] [Related]  

  • 9. American Mistletoe as an Oxytocic and Emmenagogue.
    Carter JMG
    Chic Med J Exam; 1888 Jun; 56(6):336-337. PubMed ID: 37619113
    [No Abstract]   [Full Text] [Related]  

  • 10. Coley's Lessons Remembered: Augmenting Mistletoe Therapy.
    Orange M; Reuter U; Hobohm U
    Integr Cancer Ther; 2016 Dec; 15(4):502-511. PubMed ID: 27207233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects.
    Huber R; Lüdtke H; Wieber J; Beckmann C
    BMC Complement Altern Med; 2011 Nov; 11():116. PubMed ID: 22114899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.
    Heinzerling L; von Baehr V; Liebenthal C; von Baehr R; Volk HD
    J Clin Immunol; 2006 Jul; 26(4):347-59. PubMed ID: 16705487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.
    Klein R; Classen K; Berg PA; Lüdtke R; Werner M; Huber R
    Eur J Med Res; 2002 Apr; 7(4):155-63. PubMed ID: 12010650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
    Stettin A; Schultze JL; Stechemesser E; Berg PA
    Klin Wochenschr; 1990 Sep; 68(18):896-900. PubMed ID: 2124308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of different antigens of mistletoe extracts by anti-mistletoe lectin antibodies.
    Stein GM; Pfüller U; Berg PA
    Cancer Lett; 1999 Jan; 135(2):165-70. PubMed ID: 10096425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM; Stettin A; Schultze J; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.